Ursprung des Netzwerks ersten Grades von Meg Lewis
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Meg Lewis
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Rockhurst University | College/University | Undergraduate Degree | |
| CHIMERIC THERAPEUTICS LIMITED | Biotechnology | Corporate Officer/Principal | |
| KITE PHARMA INC | Biotechnology | Corporate Officer/Principal | |
| Keane Consulting, Inc. | Director of Finance/CFO | ||
Elanco Tiergesundheit AG
 Elanco Tiergesundheit AG Pharmaceuticals: MajorHealth Technology Elanco Tiergesundheit AG manufactures animal vaccines. The firm provides pet health, livestock and Bioprotection products. The company's products include Atopica, Capstar, Deramaxx, Fortekor, Interceptor, Milbemax, Parc-tic and Sentinel. It is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director of Finance/CFO | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Novartis Vaccines & Diagnostics, Inc.
 Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
WeSana Health, Inc.
 WeSana Health, Inc. Pharmaceuticals: MajorHealth Technology Part of Wesana Health Holdings, Inc., WeSana Health, Inc. engages in the development and delivery of psychedelic and naturally-sourced therapies. The company is based in Homer Glen, IL. The company was founded by Daniel Carcillo, Chad Bronstein. Daniel Carcillo has been the CEO since incorporation. WeSana Health was acquired by Debut Diamonds, Inc. on April 28, 2021. | Pharmaceuticals: Major | Chief Operating Officer | |
| WESANA HEALTH HOLDINGS INC. | Biotechnology | Founder | |
Lykos Therapeutics PBC
 Lykos Therapeutics PBC BiotechnologyHealth Technology Part of Multidisciplinary Association for Psychedelic Studies, Lykos Therapeutics, Inc. is a public benefit corporation that focuses on developing and commercializing prescription psychedelics to provide better treatments for people with mental health conditions. The private company is based in San Jose, CA. Lykos Therapeutics aims to catalyze healing and well-being through psychedelic drug development, therapist training programs, and sales of prescription psychedelics, prioritizing public benefit above profit. The company was founded in 2014, and the CEO is Amy Emerson. | Biotechnology | Chairman | |
Progressive Therapeutics, Inc.
 Progressive Therapeutics, Inc. BiotechnologyHealth Technology Progressive Therapeutics, Inc. engages in the development of novel therapeutics. The company is based in Orleans, MA. | Biotechnology | President | |
| The University of Texas at Austin | College/University | Undergraduate Degree | |
Edgemont Pharmaceuticals LLC
 Edgemont Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Edgemont Pharmaceuticals LLC develops and provides products for psychiatric disorders. The company was founded by Douglas A. Saltel in 2008 and is headquartered in Austin, TX. | Pharmaceuticals: Major | Sales & Marketing | |
| XENOPORT, INC. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistik
International
| Vereinigte Staaten | 14 |
| Australien | 2 |
| Schweiz | 2 |
Sektoral
| Health Technology | 13 |
| Consumer Services | 3 |
Operativ
| Corporate Officer/Principal | 9 |
| Chief Operating Officer | 3 |
| Director of Finance/CFO | 3 |
| Undergraduate Degree | 2 |
| Founder | 1 |
